Semax vs N-Acetyl Semax: How Do They Differ?

Structural distinction: N-terminal free amino vs. acetyl modification

Semax and N-Acetyl Semax differ by a single chemical modification at the N-terminus. Semax presents a free primary amine (-NH2) on the N-terminal methionine residue. N-Acetyl Semax carries an acetyl group (-COCH3) covalently bonded to this N-terminal amino group via an amide bond, converting the primary amine to a secondary amide (-NHCOCH3). This acetylation modification increases the peptide's molar mass by 43 Da (from approximately 888 Da to 931 Da), representing addition of a two-carbon, one-nitrogen, one-oxygen substituent. The structural change is minimal by molar mass percentage but alters the peptide's electrostatic properties significantly.In vitro · PMID 35080861Review · PMID 34862849

Both peptides maintain the identical heptapeptide sequence: Met-Glu-His-Phe-Pro-Gly-Pro. The acetyl modification does not alter the peptide backbone structure, amino acid residues, or the metal-coordinating histidine residue at position 3. Rather, it adds a single functional group at the protein N-terminus. This distinction makes the two peptides chemically distinct despite their sequence identity, resembling the posttranslational acetylation modifications documented in naturally occurring peptides and proteins.In vitro · PMID 35080861

Acetylation impacts on overall charge and electrostatic properties

The N-terminal acetylation modification substantially alters the peptide's charge distribution and electrostatic properties. Semax's free N-terminal amino group carries a positive charge at physiological pH (approximately +1.0 charge at pH 7.4, depending on pKa). The conversion to an acetylated secondary amide neutralizes this charge, making N-Acetyl Semax electrically neutral at the N-terminus. This charge elimination changes the peptide's net positive charge, altering its behavior in ion-exchange chromatography, its interactions with negatively charged molecules and surfaces, and its solubility in aqueous solutions. Protein aggregation research has documented that N-terminal modifications alter the peptide's propensity to aggregate and its susceptibility to various biochemical stresses.In vitro · PMID 35080861Review · PMID 34862849

The acetyl modification affects the peptide's isoelectric point (pI), the pH at which the molecule carries no net charge. Acetylation lowers the pI by removing one source of positive charge. This shift changes the peptide's solubility across the pH range, its binding to charged surfaces, and its migration in electrophoretic techniques. The reduced positive charge in N-Acetyl Semax may decrease its affinity for negatively charged cellular components and surfaces compared to the cationic Semax.Review · PMID 34862849

Biochemical properties and peptide stability differences

The N-terminal acetylation modification affects resistance to proteolytic degradation. Semax's free N-terminal amino group serves as a recognition site for exopeptidases, enzymes that specifically cleave peptides from the terminal positions. Exopeptidases recognize and bind to free N-terminal or C-terminal groups, making acetylated peptides potential substrates for different protease enzymes. N-Acetyl Semax's blocked N-terminus prevents recognition and cleavage by exopeptidases that specifically require a free N-terminal amino group, potentially conferring differential stability in in-vitro proteolysis assays.In vitro · PMID 35080861Review · PMID 31088827

In-vitro proteolytic degradation studies comparing peptides with and without N-terminal acetylation have documented differences in degradation kinetics. The acetyl group shields the N-terminal amine from proteolytic attack, increasing the resistance of N-Acetyl Semax to exopeptidase-mediated cleavage. However, endopeptidases that cleave internal peptide bonds are unaffected by N-terminal acetylation. The overall proteolytic stability of N-Acetyl Semax depends on the balance between reduced exopeptidase activity (favorable) and unchanged endopeptidase activity (unchanged).Review · PMID 34862849

Analytical methods for distinguishing the two peptides

Semax and N-Acetyl Semax can be analytically distinguished through mass spectrometry, which directly measures the 43 Da molar mass difference. High-resolution electrospray ionization mass spectrometry (ESI-MS) resolves the two peptides definitively based on their intact molar masses: semax at 888 Da and N-Acetyl Semax at 931 Da. Tandem mass spectrometry (MS/MS) with collision-induced dissociation generates fragment ions characteristic of each peptide, with N-Acetyl Semax showing retention of the acetyl group on fragments containing the N-terminus.In vitro · PMID 35080861

Ion-exchange chromatography separates the two peptides based on their different charge distributions. Semax's higher net positive charge causes it to elute later (or earlier, depending on the resin type) than N-Acetyl Semax from ion-exchange columns. Reversed-phase high-performance liquid chromatography (HPLC) with hydrophobic stationary phases shows differential retention due to the subtle changes in hydrophobicity resulting from the acetyl modification. Edman sequencing—the stepwise degradation of the N-terminal amino acid—is blocked at the N-terminal position of N-Acetyl Semax, confirming acetylation status.In vitro · PMID 35080861

Metal binding and in-vitro biochemical interactions

Both semax variants contain the same metal-coordinating residues: the histidine imidazole at position 3 and a free amino group. However, N-Acetyl Semax's blocked N-terminal amino group cannot participate in metal coordination, leaving only the histidine residue as a available coordination site. Copper(II) coordination studies comparing the two peptides would be expected to show differences in binding affinity and coordination geometry, with N-Acetyl Semax potentially exhibiting monodentate (single-site) copper binding through histidine alone, while Semax offers bidentate (dual-site) binding through both the N-terminus and histidine. Research on protein aggregation has characterized how N-terminal modifications influence metal-dependent cross-linking and the formation of higher-order peptide complexes.In vitro · PMID 35080861In vitro · PMID 25310602

In-vitro cell-based studies examining the two semax variants measure whether the N-terminal acetylation produces functional differences in cultured cell systems. Comparative cell-based assays using identical concentrations and exposure methods would reveal whether the structural modification alters receptor binding, intracellular signaling, or other cell-autonomous responses. Such comparative studies characterize potential functional consequences of the single N-terminal modification in defined laboratory conditions. Parallel measurements of both peptide variants at equivalent concentrations and incubation times permit direct assessment of whether acetylation changes cellular readouts.In vitro · PMID 35080861

The studies at a glance

Structural, analytical, and biochemical comparison of semax and N-Acetyl Semax

Frequently asked questions